OraSure Technologies Inc
Change company Symbol lookup
Select an option...
OSUR OraSure Technologies Inc
MRDY Mobile Ready Entertainment Corp
MANT ManTech International Corp
LXFR Luxfer Holdings PLC
SYZLF Sylogist Ltd
BSX Boston Scientific Corp
PNGAY Ping An Insurance Group Co of China Ltd
GLOP GasLog Partners LP
AGNC Agnc Investment Corp
TSOEX TIAA-CREF Social Choice International Equity Fund (Retirement)
Go

Health Care : Health Care Equipment & Supplies | Small Cap Blend
Company profile

OraSure Technologies, Inc. (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types. The Company operates in two segments: OSUR and DNAG. OSUR consists of the development, manufacture and sale of diagnostic products, specimen collection devices, and medical devices. DNAG or molecular collection systems business consists primarily of the development, manufacture and sale of oral fluid collection devices that are used to collect, stabilize, and store samples of genetic material for molecular testing.

Premarket

Last Trade
Delayed
$10.56
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$10.56
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
4

10-day average volume:
1,337,194
4

Insignia and Partners Support CDC Demonstration Project for Uptake of Self-test Kits for HIV

6:00 am ET May 10, 2021 (Globe Newswire) Print

Insignia Federal Group, LLC, along with partners Building Healthy Online Communities (BHOC), Emory University, Keymind (a Division of Axiom Resource Management), and OraSure Technologies, Inc. (NASDAQ: OSUR), was selected by the Centers for Disease Control and Prevention (CDC) to distribute 100,000 HIV self-test kits -- mailed in discreet packaging, at no charge, to individuals who request them.

The program will send out OraQuick In-Home HIV Tests, which allow an individual to detect antibodies to both HIV-1 and HIV-2 with an oral swab, and provides a result in 20 minutes, at home. The tests are the only oral fluid rapid over-the-counter HIV test approved in the U.S. If the test shows a positive result, users will be directed to go to a health care provider for follow-up testing.

"We're excited to make these kits available for free to anyone in the United States who's eligible to receive them, particularly in those communities disproportionately affected by HIV/AIDS, and to assist the CDC's efforts to end the HIV epidemic," said Karen Lee, President of Insignia. "During these times of the COVID pandemic, it is even more important to provide at-home alternatives for testing."

An estimated 1.2 million people in the United States have HIV, including about 161,800 who are unaware of their status. Nearly 40% of new HIV infections are transmitted by people who don't know they have HIV. Important barriers to HIV testing include underestimation of risk, stress in waiting for test results, and difficulty finding time to test. Expanding on BHOC's TakeMeHome program, which currently offers HIV test kits through participating health jurisdictions, this project as part of CDC's Let's Stop HIV Together campaign will offer national distribution starting in 2021 and will run for approximately one year until all 100,000 kits are delivered. Individuals can request a kit by visiting https://bit.ly/2QL4pv3.

This large-scale and targeted distribution of self-test kits will assist CDC in its efforts to increase HIV testing among gay and bisexual men, transgender women, and racial and ethnic minorities and contribute to the Ending the HIV Epidemic in the U.S. (EHE) initiative. In addition to improving and maintaining the health of people with HIV, HIV testing is the bridge to treatment and prevention.

"The first step towards ending the HIV epidemic is to know your HIV status. We are honored to work with this exceptional group of partner organizations and CDC to make our OraQuick In-Home HIV Tests more accessible to the people who need them," said Stephen S. Tang, President and Chief Executive Officer of OraSure Technologies. "We stand ready to help people in the community know their HIV status and link them to appropriate care."

Insignia

Insignia Federal Group is a woman owned small business (WOSB) providing professional consulting and information technology services to public sector clients. Services include program and performance management, software and digital services, data science and data visualization, user experience and accessibility of systems, and training solutions. www.insigniafederal.com

Building Healthy Online Communities (BHOC), co-founded and directed by Jen Hecht, is a consortium of public health leaders and gay dating website and app owners who are working together to support HIV and sexually transmitted infection (STI) prevention online. BHOC collaborates with app owners to promote testing, provide accurate information, reduce stigma, and implement the most effective interventions to reduce the impact of HIV and STIs. BHOC launched TakeMeHome in March 2020. BHOC is currently housed at San Francisco AIDS Foundation. www.bhocpartners.org

Emory University

Emory's team is led by Dr. Patrick Sullivan, an infectious disease epidemiologist at Emory's Rollins School of Public Health. Dr. Sullivan served for 14 years in CDC's Division of AIDS Prevention (DHAP) and was the Principal Investigator for CDC's eSTAMP study, which established the benefits of distribution of HIV self-tests, as well as CDC's iSTAMP study, a large implementation study of the distribution of HIV self-test kits. https://sph.emory.edu/index.html

Keymind, Division of Axiom Resource Management, Inc. Keymind is a digital services consulting firm with a unique combination of technical and creative services. Keymind has proven and repeatable software development processes -- assessed at Level 3 of Carnegie Mellon University's CMMI Institute's Software Capability Maturity Model Integration (CMMI-DEV) version 1.3. Keymind's Agile methodology provides increased speed to market, with high quality, and reduced cost and risk. http://www.keymind.com

OraSure Technologies, Inc.

OraSure Technologies, Inc. (NASDAQ: OSUR) empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly owned subsidiaries, DNA Genotek, Diversigen and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. For more information on OraSure Technologies, please visit www.orasure.com.

Media:

Karen Lee

karen_lee@insigniafederal.com

Jeanne Mell

media@orasure.com

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

https://ml.globenewswire.com/media/65692861-ef8b-490e-b730-7449593e438f/small/orasure-technologies-inc-logo.jpg

comtex tracking

COMTEX_386252665/2010/2021-05-10T06:00:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.